Skip to content

Phibro Animal Health Corp (PAHC) stock: revenue, earnings & dividend

Phibro Animal Health Corp (PAHC, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener PAHC · Nasdaq Pharma & Biotech US-NJ

Key figures

Fiscal year
2025
Revenue
1.3 bn $
Revenue growth
27.4 %
Revenue growth 5y (p.a.)
10.1 %
Net income
48.3 m $
Net margin
3.7 %
Operating margin
8.5 %
Earnings per share (diluted)
1.19 $
Dividend per share
0.48 $
Payout ratio
40.3 %
Consecutive dividend years
13 years
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
0 %
Total assets
1.41 bn $
Equity
332 m $
Equity ratio
23.7 %
Return on equity
14.5 %
Cash
55.5 m $
Operating cash flow
80.1 m $
Free cash flow
–
Shares outstanding
–

History

Revenue by fiscal year

2016 752 m $
2017 764 m $
2018 820 m $
2019 828 m $
2020 800 m $
2021 833 m $
2022 942 m $
2023 978 m $
2024 1.02 bn $
2025 1.3 bn $

Net income by fiscal year

2016 82.7 m $
2017 64.6 m $
2018 64.9 m $
2019 54.7 m $
2020 33.6 m $
2021 54.4 m $
2022 49.2 m $
2023 32.6 m $
2024 2.42 m $
2025 48.3 m $

Dividend per share

2016 0.40 $
2017 0.40 $
2018 0.40 $
2019 0.46 $
2020 0.48 $
2021 0.48 $
2022 0.48 $
2023 0.48 $
2024 0.48 $
2025 0.48 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.3 bn $48.3 m $1.19 $0.48 $80.1 m $
20241.02 bn $2.42 m $0.06 $0.48 $87.6 m $
2023978 m $32.6 m $0.81 $0.48 $13.3 m $
2022942 m $49.2 m $1.21 $0.48 $31.6 m $
2021833 m $54.4 m $1.34 $0.48 $48.3 m $
2020800 m $33.6 m $0.83 $0.48 $59.3 m $
2019828 m $54.7 m $1.35 $0.46 $47.2 m $
2018820 m $64.9 m $1.61 $0.40 $70 m $
2017764 m $64.6 m $1.61 $0.40 $98.4 m $
2016752 m $82.7 m $2.07 $0.40 $37.2 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)